DK3510167T3 - Fremgangsmåder og sammensætninger til forudsigelse af kronisk dysfunktion af lungeallotransplantation - Google Patents
Fremgangsmåder og sammensætninger til forudsigelse af kronisk dysfunktion af lungeallotransplantation Download PDFInfo
- Publication number
- DK3510167T3 DK3510167T3 DK17764388.9T DK17764388T DK3510167T3 DK 3510167 T3 DK3510167 T3 DK 3510167T3 DK 17764388 T DK17764388 T DK 17764388T DK 3510167 T3 DK3510167 T3 DK 3510167T3
- Authority
- DK
- Denmark
- Prior art keywords
- lunge
- allot
- transplant
- compositions
- methods
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/112—Disease subtyping, staging or classification
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Wood Science & Technology (AREA)
- Analytical Chemistry (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Pathology (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP16306125 | 2016-09-08 | ||
PCT/EP2017/072503 WO2018046615A1 (en) | 2016-09-08 | 2017-09-07 | Methods and compositions for predicting chronic lung allograft dysfunction |
Publications (1)
Publication Number | Publication Date |
---|---|
DK3510167T3 true DK3510167T3 (da) | 2021-11-01 |
Family
ID=56958854
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK17764388.9T DK3510167T3 (da) | 2016-09-08 | 2017-09-07 | Fremgangsmåder og sammensætninger til forudsigelse af kronisk dysfunktion af lungeallotransplantation |
Country Status (6)
Country | Link |
---|---|
US (2) | US10975438B2 (da) |
EP (1) | EP3510167B1 (da) |
DK (1) | DK3510167T3 (da) |
ES (1) | ES2893482T3 (da) |
PT (1) | PT3510167T (da) |
WO (1) | WO2018046615A1 (da) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US12013442B2 (en) * | 2018-09-28 | 2024-06-18 | Intel Corporation | In-line detection of electrical fails on integrated circuits |
WO2022064069A1 (en) * | 2020-09-28 | 2022-03-31 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Mmp-9 as a predictive marker of chronic allograft dysfunction |
CN113234830B (zh) * | 2021-06-29 | 2022-03-08 | 浙江医院 | 用于肺癌诊断的产品及用途 |
EP4177608A1 (en) | 2021-11-05 | 2023-05-10 | Medizinische Hochschule Hannover | Biomarker panel for diagnosing pulmonary dysfunction |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7741038B2 (en) * | 2005-03-14 | 2010-06-22 | The Board Of Trustees Of The Leland Stanford Junior University | Methods and compositions for evaluating graft survival in a solid organ transplant recipient |
CA2938893C (en) | 2013-02-20 | 2022-12-13 | University Health Network | Determining a normalized expression of one or more s100a and s100a9 polypeptide expression products for assessing chronic allograft dysfunction |
-
2017
- 2017-09-07 DK DK17764388.9T patent/DK3510167T3/da active
- 2017-09-07 PT PT177643889T patent/PT3510167T/pt unknown
- 2017-09-07 US US16/331,792 patent/US10975438B2/en active Active
- 2017-09-07 WO PCT/EP2017/072503 patent/WO2018046615A1/en unknown
- 2017-09-07 ES ES17764388T patent/ES2893482T3/es active Active
- 2017-09-07 EP EP17764388.9A patent/EP3510167B1/en active Active
-
2021
- 2021-03-09 US US17/196,853 patent/US11814683B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
US20210404000A1 (en) | 2021-12-30 |
US11814683B2 (en) | 2023-11-14 |
ES2893482T3 (es) | 2022-02-09 |
EP3510167B1 (en) | 2021-08-04 |
EP3510167A1 (en) | 2019-07-17 |
US20190226027A1 (en) | 2019-07-25 |
WO2018046615A1 (en) | 2018-03-15 |
US10975438B2 (en) | 2021-04-13 |
PT3510167T (pt) | 2021-10-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK3842442T3 (da) | Sammensætninger og fremgangsmåder til hæmning af arginaseaktivitet | |
DK3212778T3 (da) | Fremgangsmåder og sammensætninger til stabilisering af trans-splejsning af intein-modificerede proteaser | |
DK3368541T3 (da) | Sammensætninger og metoder til inhibiering af arginaseaktivitet | |
DK3484469T3 (da) | Sammensætninger og fremgangsmåder til potentiering af antimikrober | |
DK3282836T3 (da) | Fremgangsmåde til opdræt af insekter | |
DK3110975T3 (da) | Fremgangsmåder til analyse af somatiske mobile elementer og anvendelser deraf | |
DK3277717T3 (da) | En hidtil ukendt il33-form, muterede former af il33, antistoffer, assays og fremgangsmåder til anvendelse deraf | |
DK3256604T3 (da) | Fremgangsmåder og sammensætninger til analyse af cellebestanddele | |
DK3423451T3 (da) | Inhibitorer af wdr5-protein-proteinbinding | |
DK3148579T3 (da) | Anti-gitr antistoffer og fremgangsmåder til anvendelse deraf | |
DK3292134T3 (da) | Metode til dyrkning af akkermansia | |
DK3152312T3 (da) | Fremgangsmåder og sammensætninger til modifikation af et mållocus | |
DK3316909T3 (da) | Anti-ntb-a-antistoffer og relaterede sammensætninger og fremgangsmåder | |
DK3250210T3 (da) | Sammensætninger og fremgangsmåder til behandling af cns-forstyrrelser | |
DK3484916T3 (da) | Antistoffer specifikke for hyperphosphoryleret tau og fremgangsmåder til anvendelse deraf | |
DK3519572T3 (da) | Forbindelser og fremgangsmåder til reduktion af tau-ekspression | |
DK3250610T3 (da) | Fcrn-antistoffer og fremgangsmåder til anvendelse heraf | |
DK3144001T3 (da) | Sammensætninger af selenoorganiske forbindelser og fremgangsmåder til anvendelse deraf | |
DK3399985T3 (da) | Sammensætninger og biblioteker, der omfatter rekombinante T-cellereceptorer, og fremgangsmåder til anvendelse af rekombinante T-cellereceptorer | |
DK3393655T3 (da) | Fenfluramin-sammensætninger og fremgangsmåder til fremstilling af samme | |
DK3071215T3 (da) | Sammensætninger og fremgangsmåder til behandling af pulmonal hypertension | |
DK3319948T3 (da) | Acesulfam-kaliumsammensætninger og fremgangsmåder til fremstilling af disse | |
DK3322695T3 (da) | Acesulfam-kalium-sammensætninger og fremgangsmåder til fremstilling af disse | |
DK3280440T3 (da) | Humaniserede anti-c1s-antistoffer og fremgangsmåder til anvendelse deraf | |
DK3394259T3 (da) | Sammensætninger og fremgangsmåder til reducering af tau-ekspression |